249823 Report on the Evaluation of the Effectivenes of USG Foreign Aid

Tuesday, November 1, 2011: 1:00 PM

Kelly Heindel , Suite 300, Social Impact, Arlington
The Paris Declaration on Aid Effectiveness and the subsequent Accra Agenda for Action was signed by the United States in 2005. Although several US departments engaged in foreign assistance modeled their programs on Paris Declaration principles, notably MCC and, in 2008/9 PEPFAR, the Obama administration's efforts to implement a comprehensive reform of USG foreign assistance programs has given new and greater impetus and attention to the Paris Declaration and aid effectiveness principles in general. In January 2010, the USG joined an international effort to conduct an independent review of its commitment to and efforts towards implementing the Paris Declaration. The Office of the Director of Foreign Assistance at State and USAID hired Social Impact, Inc. to carry out this evaluation, which included seven individual agency case studies (DOS, USAID, MCC, HHS, TREAS, USDA, and DOL) and a synthesis report analyzing the USG efforts overall. The Social Impact team will discuss this year and a half long evaluation, including major findings, conclusions, and matters for further consideration.

Learning Areas:
Other professions or practice related to public health
Program planning

Learning Objectives:
1. Discuss ways to improve coordination in the execution of development aid assistance in global health 2. List ways to improve the measurement and accountability for the results of global health aid

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Ms. Heindel conducted the evaluation at request of USAID and the Department of State.
Any relevant financial relationships? Yes

Name of Organization Clinical/Research Area Type of relationship
Social Impact research Employment (includes retainer)

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.